In tumors, SOX2 is up-regulated in early pancreatic cancer lesions [46], where it is nuclear in basal cells or in the vicinity of necrotic areas and is activated in a majority of advanced tumors [47]. The gene discussed is SOX2; the disease is familial pancreatic carcinoma.